PrEP is an effective way to prevent HIV; however, several key populations, including cisgender women, have not seen optimal uptake for prevention. Following NCSD’s webinar series on promoting PrEP in women, this webinar covers clinical considerations for prescribing PrEP in cisgender women/individuals assigned female at birth.